Date published: 2026-4-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

S19BP Inhibitors

S19BP inhibitors represent a class of chemical compounds that target and modulate the activity of the S19-binding protein (S19BP), a key component involved in regulating various biochemical pathways. S19BP is a molecular entity that functions primarily as a binding partner within protein complexes, interacting with specific substrates to influence metabolic, enzymatic, or regulatory mechanisms within cells. The inhibitors of S19BP function by interfering with the binding dynamics between the protein and its associated substrates, often through direct binding to the active or allosteric sites of S19BP. This disruption can result in alterations to the downstream molecular processes that S19BP is involved in, affecting protein folding, cellular signaling, or catalytic activities within a variety of biochemical contexts. Inhibitors of this class may exhibit selectivity based on their structural compatibility with the binding pockets of S19BP, which are typically shaped by specific amino acid residues or motifs that contribute to its molecular recognition features.

At a chemical level, S19BP inhibitors often exhibit a range of structural diversity, but they are unified by their ability to modulate protein-protein interactions. Many of these inhibitors possess functional groups that mimic or compete with the natural substrates of S19BP, thereby preventing the formation of productive protein complexes. The design of such inhibitors typically involves the identification of molecular features such as hydrophobic pockets, hydrogen-bond donors and acceptors, or electrostatic interactions that facilitate binding. Advanced techniques like structure-based drug design (SBDD) and computational modeling are frequently used to optimize the affinity and specificity of these inhibitors. The chemical properties of S19BP inhibitors, including their solubility, stability, and binding kinetics, play significant roles in determining their efficiency in modulating the protein's biological functions. Through detailed characterization, S19BP inhibitors offer a fascinating avenue for studying the regulatory mechanisms governed by this protein in various biological systems.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$41.00
$84.00
$275.00
127
(6)

Inhibits eukaryotic protein synthesis by interfering with the translocation step in ribosomes, potentially affecting RPS19BP1.

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$63.00
$158.00
$326.00
233
(4)

Inhibits mTOR, a key regulator of protein synthesis, possibly influencing RPS19BP1 through global protein synthesis control.

Chloramphenicol

56-75-7sc-3594
25 g
$90.00
10
(1)

Binds to bacterial ribosomes, inhibiting protein synthesis; could indirectly affect RPS19BP1 in similar eukaryotic contexts.

Puromycin dihydrochloride

58-58-2sc-108071
sc-108071B
sc-108071C
sc-108071A
25 mg
250 mg
1 g
50 mg
$42.00
$214.00
$832.00
$66.00
394
(16)

Causes premature chain termination in protein synthesis; could impact RPS19BP1 indirectly by disrupting ribosomal activity.

Emetine

483-18-1sc-470668
sc-470668A
sc-470668B
sc-470668C
1 mg
10 mg
50 mg
100 mg
$440.00
$900.00
$1400.00
$2502.00
(0)

Inhibits protein synthesis in eukaryotes, potentially affecting RPS19BP1 function by blocking ribosomal translocation.

Tetracycline

60-54-8sc-205858
sc-205858A
sc-205858B
sc-205858C
sc-205858D
10 g
25 g
100 g
500 g
1 kg
$63.00
$94.00
$270.00
$417.00
$634.00
6
(1)

Binds to the 30S subunit of bacterial ribosomes; its mechanism could indirectly affect RPS19BP1 in eukaryotes.

Anisomycin

22862-76-6sc-3524
sc-3524A
5 mg
50 mg
$99.00
$259.00
36
(2)

Inhibits peptide elongation in eukaryotic ribosomes, possibly impacting RPS19BP1 by disrupting ribosomal assembly.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$74.00
$243.00
$731.00
$2572.00
$21848.00
53
(3)

Interferes with DNA-dependent RNA synthesis, potentially impacting RPS19BP1 by affecting ribosomal RNA synthesis.

Phleomycin

11006-33-0sc-204845
sc-204845A
5 mg
25 mg
$195.00
$495.00
(1)

Inhibits peptidyl transferase activity in ribosomes, potentially affecting RPS19BP1's role in ribosome function.

Chondroitin Sulfate, Bovine

9007-28-7sc-203888
5 g
$94.00
1
(1)

Inactivates eukaryotic elongation factor 2 (EF-2), possibly affecting RPS19BP1 by disrupting protein synthesis processes.